Radiopharmaceutical Device Development Explained

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Radiopharmaceutical Device Development Explained

Sector: Diagnostics
Topic: Bio Break
YouTube video thumbnail

Radiopharmaceutical device development is gaining momentum as medical teams explore new frontiers in diagnostic imaging and cancer treatment. In this episode of Bio Break, Nigel and Nick dive into how radioisotopes are used in both therapeutic and imaging applications—and what it means for engineers designing devices that handle radiation safely.

Nigel explains how these radioactive compounds—like radiolabeled glucose—can help detect cancer by highlighting areas of high metabolic activity in the body. The technique is based on how tumors often consume more glucose than surrounding tissue. So when tagged with a tracer like FDG (fluorodeoxyglucose), those hotspots become visible.

Nick shares his own experience using these radiopharmaceuticals in drug delivery trials. He describes a study comparing radiolabeled compounds that either do or do not cross the blood-brain barrier. By using FDG as a positive control and FLT (fluorothymidine) as a negative control, his team was able to track how a drug reached—or failed to reach—the brain.

As device developers, the implications are clear. Designing tools that safely handle radioactive materials requires special care. From the initial generator to the final “daughter” isotopes used in patients, radiopharmaceutical workflows are complex, fast-moving, and full of potential.

For medical device innovators, this space offers exciting opportunities—especially as demand for targeted therapies and precise imaging continues to grow.

Learn more about StarFish Medical.

Gloved hands insert a swab into a sealed vial beside a crossed-out O₂ symbol with the text “No Oxygen Allowed?” illustrating anaerobic sample collection.

Anaerobic Sample Collection Explained

Nick Allan joins Nigel Syrotuck to explore how anaerobic sample collection works and why it’s vital for studying bacteria that cannot survive in oxygen.

Thumbnail showing “First to Invent” with yellow exclamation marks transitioning via red arrow to “First to File” with a folder of patent documents, illustrating the shift in patent rules discussed in the Bio Break episode.

Patent Documentation Habits

Nick Allan and Nigel Syrotuck dive into the evolution of patent documentation habits in engineering and medical device development.

Thumbnail showing a medical sampling pipette with a red arrow pointing to a microscope under the text “Repurposed for Research?” illustrating medical device adaptation in scientific studies.

Device Repurposing in Research

Nick Allan and Nigel Syrotuck discuss device repurposing in research, sharing a story that blends microbiology, animal science, and engineering ingenuity.

96-well lab plates with a red arrow pointing to a green recycling symbol, representing lab plastic recycling for sustainability in medtech.

Lab Plastic Recycling in Medtech

Nick Allan and Nigel Syrotuck explore the massive volume of single-use plastic in labs and discuss a new company working to close the loop through a circular economy approach.